Pro Medicus Limited (ASX: PME), recorded a surge in underlying net profit after tax of 83.1% to $22.74 million. During FY19, PME announced several new contracts win in North America.
- PME remains cash flow positive- cash increased from $25 million to $32 million after paying an increased dividend;
- The declared dividend of 10.5 cents per share for FY19 depicts an increase of 75% over the previous year;
- In June 2019 the company was included in the ASX 200, meeting the criteria of market capitalisation and liquidity.
At AEST 01:16PM, the stock was trading at $24.660 per share, down by 5.1% from its previous close.